These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38051662)

  • 41. Evaluation of a chromogenic assay to measure the factor Xa inhibitory activity of unfractionated heparin in canine plasma.
    Brooks MB
    Vet Clin Pathol; 2004; 33(4):208-14. PubMed ID: 15570557
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Monitoring of Unfractionated Heparin in Severe COVID-19: An Observational Study of Patients on CRRT and ECMO.
    Streng AS; Delnoij TSR; Mulder MMG; Sels JWEM; Wetzels RJH; Verhezen PWM; Olie RH; Kooman JP; van Kuijk SMJ; Brandts L; Ten Cate H; Lorusso R; van der Horst ICC; van Bussel BCT; Henskens YMC
    TH Open; 2020 Oct; 4(4):e365-e375. PubMed ID: 33235946
    [No Abstract]   [Full Text] [Related]  

  • 43. Heparin dosage, level, and resistance in SARS-CoV2 infected patients in intensive care unit.
    Novelli C; Borotto E; Beverina I; Punzi V; Radrizzani D; Brando B
    Int J Lab Hematol; 2021 Dec; 43(6):1284-1290. PubMed ID: 33855802
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of exogenous antithrombin on low molecular weight heparin anti-Xa activity assays in a pediatric and young adult leukemia and lymphoma cohort with variable antithrombin levels.
    Schaefer B; Hausfeld A; Martin M; Steele P; Martin J; Reher SR; Lane A; Luchtman-Jones L
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28654. PubMed ID: 32841498
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Use of heparin calibrated anti-Xa assay for apixaban and rivaroxaban measurement in the context of regional telestroke activity].
    Delassasseigne C; Leroux C; Renou P; Girard D; Lafargue A; Morel S; Belotti PT; Weinmann L
    Ann Biol Clin (Paris); 2023 Jul; 81(3):269-279. PubMed ID: 37329142
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of Coagulation Factors Activity in Different Types of Plasma Preparations.
    Afifi OAH; Abdelsalam EMN; Makhlouf AAEAM; Ibrahim MAM
    Indian J Hematol Blood Transfus; 2019 Jul; 35(3):551-556. PubMed ID: 31388272
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A global comparative field study to evaluate the factor VIII activity of efanesoctocog alfa by one-stage clotting and chromogenic substrate assays at clinical haemostasis laboratories.
    Pipe S; Sadeghi-Khomami A; Konkle BA; Kitchen S; Negrier C; Liu M; Santagostino E; Willemze A; Abad-Franch L; Knobe K; Seth Chhabra E
    Haemophilia; 2024 Jan; 30(1):214-223. PubMed ID: 37902390
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the Succeeder SF-8200 Fully Automated Coagulation Analyzer.
    Zengi O; Kucuk SH
    Clin Lab; 2021 Oct; 67(10):. PubMed ID: 34655207
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pre-analytical stability of coagulation parameters in plasma stored at room temperature.
    Linskens EA; Devreese KMJ
    Int J Lab Hematol; 2018 Jun; 40(3):292-303. PubMed ID: 29405578
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neonatal haemostatic parameters in correlation to gestational age and birth weight.
    Mitsiakos G; Katsaras GN; Pouliakis A; Papadakis E; Chatziioannidis I; Mitsiakou C; Gialamprinou D; Papacharalampous E; Kioumi A; Athanasiou M; Athanassiadou F; Sfoungaris D; Nikolaidis N
    Int J Lab Hematol; 2022 Oct; 44(5):952-958. PubMed ID: 35815444
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparative evaluation of the CN-6000 haemostasis analyser using coagulation, amidolytic, immuno-turbidometric and light transmission aggregometry assays.
    Gardiner C; Lane P; Langley K; Tailor H; Machin SJ; Mackie IJ
    Int J Lab Hematol; 2020 Oct; 42(5):643-649. PubMed ID: 32885901
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systematic Comprehensive Evaluation of the Mindray CX-9000 Coagulation Analyzer Performance.
    Wu Y; Chen S; Xiao D; Liu M; Lan X; Zhang L; Liu J; Yuan X; Huang T; Song C; He H
    Clin Lab; 2023 Aug; 69(8):. PubMed ID: 37560874
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monitoring of Unfractionated Heparin Therapy in the Intensive Care Unit Using a Point-of-Care aPTT: A Comparative, Longitudinal Observational Study with Laboratory-Based aPTT and Anti-Xa Activity Measurement.
    Lardinois B; Hardy M; Michaux I; Horlait G; Rotens T; Jacqmin H; Lessire S; Bulpa P; Dive A; Mullier F
    J Clin Med; 2022 Feb; 11(5):. PubMed ID: 35268436
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The stability of 'add-on' coagulation assays in refrigerated citrated plasma stored on a packed cellular fraction.
    Quirke W; Toomey S; Sheikhi A
    Int J Lab Hematol; 2021 Aug; 43(4):779-785. PubMed ID: 33991057
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays.
    Lindahl TL; Baghaei F; Blixter IF; Gustafsson KM; Stigendal L; Sten-Linder M; Strandberg K; Hillarp A;
    Thromb Haemost; 2011 Feb; 105(2):371-8. PubMed ID: 21103660
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-idiotype monoclonal antibodies against emicizumab enable accurate procoagulant and anticoagulant assays, irrespective of the test base, in the presence of emicizumab.
    Ogiwara K; Furukawa S; Shinohara S; Tabuchi Y; Arai N; Noguchi-Sasaki M; Soeda T; Shima M; Nogami K
    Haemophilia; 2023 Jan; 29(1):329-335. PubMed ID: 36137299
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Study on commutability evaluation of reference materials for fibrinogen].
    Liu YH; Li CB; Zhou WB; Peng MT
    Zhonghua Yi Xue Za Zhi; 2019 Jul; 99(26):2062-2067. PubMed ID: 31315378
    [No Abstract]   [Full Text] [Related]  

  • 58. Is it acceptable to use coagulation plasma samples stored at room temperature and 4°C for 24 hours for additional prothrombin time, activated partial thromboplastin time, fibrinogen, antithrombin, and D-dimer testing?
    Rimac V; Coen Herak D
    Int J Lab Hematol; 2017 Oct; 39(5):475-481. PubMed ID: 28488785
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of apixaban on commonly used coagulation assays: results from the Belgian national External Quality Assessment Scheme.
    Van Blerk M; Bailleul E; Chatelain B; Demulder A; Devreese K; Douxfils J; Jacquemin M; Jochmans K; Mullier F; Wijns W; China B; Vernelen K; Soumali MR
    Int J Lab Hematol; 2017 Aug; 39(4):402-408. PubMed ID: 28304137
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
    Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
    Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.